Keshava Datta

Dr. Keshava Datta


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
SASakshi Agarwal
Sakshi Agarwal
ASArun Sharma
Arun Sharma
RBRania Bouzeyen
Rania Bouzeyen
ADAmar Deep
Amar Deep
HSHarsh Sharma
Harsh Sharma
RSRamandeep Singh
Ramandeep Singh
The VapBC22 toxin-antitoxin system regulates adaptation to oxidative stress and virulence in Mycobacterium tuberculosis .

26 February 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
PBPriyanka Bansal
Priyanka Bansal
NANeelam Antil
Neelam Antil
MKManish Kumar
Manish Kumar
YYYoshiki Yamaryo-Botté
Yoshiki Yamaryo-Botté
RRRahul Singh Rawat
Rahul Singh Rawat
PSPushkar Sharma
Pushkar Sharma
Apicomplexan parasites are causative agents of major human diseases. Calcium Dependent Protein Kinases (CDPKs) are crucial components for the intracellular development of apicomplexan parasites and are thus considered attractive drug targets. CDPK7 is an atypical member of this family, which initial characterization suggested to be critical for intracellular development of both Apicomplexa Plasmodium falciparum and Toxoplasma gondii. However, the mechanisms via which it regulates parasite replication have remained unknown. We performed quantitative phosphoproteomics of T. gondii lacking TgCDPK7 to identify its parasitic targets. Our analysis lead to the identification of several putative TgCDPK7 substrates implicated in critical processes like phospholipid (PL) synthesis and vesicular trafficking. Strikingly, phosphorylation of TgRab11a via TgCDPK7 was critical for parasite intracellular development and protein trafficking. Lipidomic analysis combined with biochemical and cellular studies confirmed that TgCDPK7 regulates phosphatidylethanolamine (PE) levels in T. gondii. These studies provide novel insights into the regulation of these processes that are critical for parasite development by TgCDPK7.

21 August 2019 in Cells
Verified
Journal Article
Open access
PDF file
KDKeshava K. Datta
Keshava K. Datta
Shankargouda PatilShankargouda Patil
Shankargouda Patil
KPKrishna Patel
Krishna Patel
NBNiraj Babu
Niraj Babu
RRRemya Raja
Remya Raja
HGHarsha Gowda
Harsha Gowda
Tobacco in its smoke and smokeless form are major risk factors for esophageal squamous cell carcinoma (ESCC). However, molecular alterations associated with smokeless tobacco exposure are poorly understood. In the Indian subcontinent, tobacco is predominantly consumed in chewing form. An understanding of molecular alterations associated with chewing tobacco exposure is vital for identifying molecular markers and potential targets. We developed an in vitro cellular model by exposing non-transformed esophageal epithelial cells to chewing tobacco over an eight-month period. Chronic exposure to chewing tobacco led to increase in cell proliferation, invasive ability and anchorage independent growth, indicating cell transformation. Molecular alterations associated with chewing tobacco exposure were characterized by carrying out exome sequencing and quantitative proteomic profiling of parental cells and chewing tobacco exposed cells. Quantitative proteomic analysis revealed increased expression of cancer stem cell markers in tobacco treated cells. In addition, tobacco exposed cells showed the Oxidative Phosphorylation (OXPHOS) phenotype with decreased expression of enzymes associated with glycolytic pathway and increased expression of a large number of mitochondrial proteins involved in electron transport chain as well as enzymes of the tricarboxylic acid (TCA) cycle. Electron micrographs revealed increase in number and size of mitochondria. Based on these observations, we propose that chronic exposure of esophageal epithelial cells to tobacco leads to cancer stem cell-like phenotype. These cells show the characteristic OXPHOS phenotype, which can be potentially targeted as a therapeutic strategy.

12 August 2021 in Proteomics
Verified
Journal Article
Closed access
PDF file
PPParthiban Periasamy
Parthiban Periasamy
SRSureka Rajandran
Sureka Rajandran
RZRebekah Ziegman
Rebekah Ziegman
MCMika Casey
Mika Casey
KNKyohei Nakamura
Kyohei Nakamura
HGHarsha Gowda
Harsha Gowda

8 March 2021 in Journal of Cell Communication and Signaling
Verified
Journal Article
Closed access
PDF file
VMVarshasnata Mohanty
Varshasnata Mohanty
Yashwanth SubbannayyaYashwanth Subbannayya
Yashwanth Subbannayya
Shankargouda PatilShankargouda Patil
Shankargouda Patil
VPVinuth N. Puttamallesh
Vinuth N. Puttamallesh
MNMohd. Altaf Najar
Mohd. Altaf Najar
ACAditi Chatterjee
Aditi Chatterjee

30 April 2021 in Cancers
Verified
Journal Article
Open access
PDF file
KDKeshava K. Datta
Keshava K. Datta
PPParthiban Periasamy
Parthiban Periasamy
SMSonali V. Mohan
Sonali V. Mohan
RZRebekah Ziegman
Rebekah Ziegman
HGHarsha Gowda
Harsha Gowda
Hypoxia is a common feature in various solid tumours, including melanoma. Cancer cells in hypoxic environments are resistant to both chemotherapy and radiation. Hypoxia is also associated with immune suppression. Identification of proteins and pathways that regulate cancer cell survival in hypoxic environments can reveal potential vulnerabilities that can be exploited to improve the efficacy of anticancer therapies. We carried out temporal proteomic and phosphoproteomic profiling in melanoma cell lines to identify hypoxia-induced protein expression and phosphorylation changes. By employing a TMT-based quantitative proteomics strategy, we report the identification and quantitation of >7000 proteins and >10,000 phosphosites in melanoma cell lines grown in hypoxia. Proteomics data show metabolic reprogramming as one of the prominent adaptive responses in hypoxia. We identify several novel hypoxia-mediated phosphorylation changes that have not been reported before. They reveal kinase signalling pathways that are potentially involved in modulating cellular response to hypoxia. In addition to known protein expression changes, we identify several novel proteomic alterations associated with adaptive response to hypoxia. We show that cancer cells require the ubiquitin–proteasome system to survive in both normoxia and hypoxia. Inhibition of proteasome activity affects cell survival and may provide a novel therapeutic avenue to target cancer cells in hypoxia. Our study can serve as a valuable resource to pursue novel candidates to target hypoxia in cancers and improve the efficacy of anticancer therapies.